TELEOST PARATHYROID RECEPTOR BIOLOGY
最新甲状旁腺受体生物学
基本信息
- 批准号:2443889
- 负责人:
- 金额:$ 2.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1997
- 资助国家:美国
- 起止时间:1997-07-01 至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The PTH/PTHrP receptor (PPR) mediates the biological actions of two
peptide hormones, PTH and PTH-related peptide (PTHrP). PTH is the major
regulator of mammalian mineral ion homeostasis. PTHrP and the common PPR
are both crucial for normal development, since the disruption of either
gene in mice results in lethal phenotypes with widespread abnormalities of
endochondral bone formation. These "knockout" studies indicated
furthermore that the common PPR is essential for mediating the functions
of PTH and PTHrP, and that no other receptor can serve as a substitute.
However, a novel, PTH-specific receptor (PTH2R) with significant amino
acid sequence homology to the PPR was isolated from mammals, but its
biological importance is not yet known. Interestingly, cDNAs encoding fish
PTH2R homologs were recently isolated also from catfish and zebrafish cDNA
libraries. If these novel receptors are activated only by PTH, as the
mammalian PTH2R homolog, these findings suggest that a PTH-like molecule
exists also in vertebrate species that do not have parathyroid glands and
that PTH expression occurs in species lacking distinct parathyroid glands.
In the current proposal, I will therefore study the coevolution and
function of two closely related G protein-coupled PTH-/PTHrP-receptors and
their two distinct ligands. The resulting findings are expected to provide
evidence for possible function(s) of both ligands and both receptors in
nonmammalian vertebrates, and may provide further clues for biological
role(s) in mammals that are distinct from those required for the control
of mineral ion homeostasis.
PTH/PTHrP 受体 (PPR) 介导两种生物作用
肽激素、PTH 和 PTH 相关肽 (PTHrP)。 PTH是主要的
哺乳动物矿物离子稳态的调节剂。 PTHrP 和普通 PPR
两者对于正常发展都至关重要,因为其中任何一个的破坏
小鼠体内的基因导致致命的表型,普遍存在异常
软骨内骨形成。这些“淘汰”研究表明
此外,共同的 PPR 对于调解职能至关重要
PTH 和 PTHrP,并且没有其他受体可以替代。
然而,一种新型 PTH 特异性受体 (PTH2R) 具有显着的氨基
与PPR同源的酸序列是从哺乳动物中分离出来的,但其
生物学重要性尚不清楚。有趣的是,编码鱼的cDNA
最近还从鲶鱼和斑马鱼 cDNA 中分离出 PTH2R 同源物
图书馆。如果这些新受体仅由 PTH 激活,则
哺乳动物 PTH2R 同源物,这些发现表明 PTH 样分子
也存在于没有甲状旁腺的脊椎动物中
PTH 表达发生在缺乏独特甲状旁腺的物种中。
因此,在当前的提案中,我将研究共同进化和
两个密切相关的 G 蛋白偶联 PTH-/PTHrP-受体的功能
它们的两个不同的配体。由此产生的结果预计将提供
两种配体和两种受体的可能功能的证据
非哺乳动物脊椎动物,并可能为生物学提供进一步的线索
在哺乳动物中的作用与控制所需的作用不同
矿物质离子稳态。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID Alan RUBIN其他文献
DAVID Alan RUBIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID Alan RUBIN', 18)}}的其他基金
Altered expression of PTH type-2 receptor and TIP39
PTH 2 型受体和 TIP39 表达改变
- 批准号:
6953844 - 财政年份:2005
- 资助金额:
$ 2.99万 - 项目类别:
Regulation of the PTH/PTHrP type-2 receptor and TIP39
PTH/PTHrP 2 型受体和 TIP39 的调节
- 批准号:
6504614 - 财政年份:2002
- 资助金额:
$ 2.99万 - 项目类别:
相似国自然基金
无脊椎动物新型受体Parathyroid hormone receptor like (PTHRL) 的鉴定及其对赤拟谷盗表皮发育的调控
- 批准号:31872970
- 批准年份:2018
- 资助金额:59.0 万元
- 项目类别:面上项目
相似海外基金
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Developing helical peptide antagonists of the growth hormone receptor
开发生长激素受体的螺旋肽拮抗剂
- 批准号:
10648820 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
- 批准号:
10762267 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)
长期隔夜禁食和/或运动对激素受体阳性晚期乳腺癌女性患者疲劳和其他患者报告结果的随机 II 期试验 (FastER)
- 批准号:
10714371 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Hypothalamic regulation by thyroid hormone receptor phosphorylation
甲状腺激素受体磷酸化对下丘脑的调节
- 批准号:
10717820 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Impact of race and ethnicity on outcomes in patients with hormone receptor-positive breast cancer treated with CDK4/6 inhibitors
种族和民族对接受 CDK4/6 抑制剂治疗的激素受体阳性乳腺癌患者预后的影响
- 批准号:
10762047 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Deep learning integration of interactome data for protein-protein interaction prediction within steroid hormone receptor complexes
类固醇激素受体复合物内蛋白质-蛋白质相互作用预测的相互作用组数据的深度学习整合
- 批准号:
BB/X018296/1 - 财政年份:2023
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant
Clinical application of non-invasive biomarkers including hormone receptor PET for endocrine resistance in breast cancer patients
激素受体PET等非侵入性生物标志物在乳腺癌患者内分泌抵抗中的临床应用
- 批准号:
22K07761 - 财政年份:2022
- 资助金额:
$ 2.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Hormone Receptor Regulation of RNA Polymerase III
RNA 聚合酶 III 的激素受体调节
- 批准号:
10662332 - 财政年份:2022
- 资助金额:
$ 2.99万 - 项目类别:
Directing luteinising hormone receptor activity in vivo: A convergent approach to study GPCR molecular complexes
体内指导黄体生成素受体活性:研究 GPCR 分子复合物的聚合方法
- 批准号:
BB/V00719X/1 - 财政年份:2022
- 资助金额:
$ 2.99万 - 项目类别:
Research Grant














{{item.name}}会员




